Comparison of the gene transfer efficiency of mRNA/GL67 and pDNA/GL67 complexes in respiratory cells.

Complexes between mRNA and GL67:DOPE:DMPE-PEG5000 (GL67) liposomes were formulated and characterized. Subsequently, the in vitro and in vivo expression characteristics of mRNA/GL67 complexes and pDNA/GL67 complexes, each produced at their optimal ratio, were compared in respiratory cells. Transfection of A549 cells with mRNA/GL67 complexes resulted in a much faster expression than after transfection with pDNA/GL67 complexes. The percentage of GFP-positive cells after mRNA and pDNA transfection peaked after 8 and 24 h, respectively. At these time points the percentage of GFP-positive cells was two times higher after mRNA transfection than after pDNA transfection. Furthermore, the efficacy of mRNA/GL67 complexes was independent of the cell cycle. This was in sharp contrast with pDNA/GL67 complexes that caused only a weak expression in nondividing cells. This confirms that the nuclear barrier is a crucial obstacle for pDNA but not for mRNA. Finally, mRNA/GL67 and pDNA/GL67 complexes encoding luciferase were administered intranasally to the lungs of mice. The mRNA/GL67 complexes did not give rise to a measurable luciferase expression in the murine lungs. In contrast, a detectable bioluminescent signal was present in the lungs of mice that received the pDNA/GL67 complexes. We showed that mRNA/GL67 complexes have a lower stability in biological fluids. Consequently, this may be an explanation for their lower performance in vivo.

[1]  D. Irvine,et al.  In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles. , 2011, Molecular pharmaceutics.

[2]  S. D. De Smedt,et al.  mRNA as gene therapeutic: how to control protein expression. , 2011, Journal of controlled release : official journal of the Controlled Release Society.

[3]  Wim E. Hennink,et al.  DNA Nuclear Targeting Sequences for Non-Viral Gene Delivery , 2011, Pharmaceutical Research.

[4]  J. Rosenecker,et al.  Expression of therapeutic proteins after delivery of chemically modified mRNA in mice , 2011, Nature Biotechnology.

[5]  B. Levine,et al.  Multiple injections of electroporated autologous T cells expressing a chimeric antigen receptor mediate regression of human disseminated tumor. , 2010, Cancer research.

[6]  N. Bavarsad,et al.  mRNA transfection of cervical carcinoma and mesenchymal stem cells mediated by cationic carriers. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[7]  Aristóbolo Mendes Silva,et al.  Intranasal vaccination with messenger RNA as a new approach in gene therapy: Use against tuberculosis , 2010, BMC biotechnology.

[8]  M. Ogris,et al.  Low generation PAMAM dendrimer and CpG free plasmids allow targeted and extended transgene expression in tumors after systemic delivery. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[9]  J. Hecker,et al.  Lipid-mediated delivery of RNA is more efficient than delivery of DNA in non-dividing cells. , 2010, International journal of pharmaceutics.

[10]  D. Dean,et al.  Progress and prospects: nuclear import of nonviral vectors , 2010, Gene Therapy.

[11]  Joseph Rosenecker,et al.  Current prospects for mRNA gene delivery. , 2009, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[12]  E. Alton,et al.  Gene transfer to the lung: lessons learned from more than 2 decades of CF gene therapy. , 2009, Advanced drug delivery reviews.

[13]  Kevin Braeckmans,et al.  Extracellular barriers in respiratory gene therapy☆ , 2008, Advanced Drug Delivery Reviews.

[14]  R. Vandenbroucke,et al.  New strategies for nucleic acid delivery to conquer cellular and nuclear membranes. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[15]  T. Tagawa,et al.  Bax mRNA therapy using cationic liposomes for human malignant melanoma , 2008, The journal of gene medicine.

[16]  L. Kobzik,et al.  Scavenger receptor class‐A is a novel cell surface receptor for double‐stranded RNA , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[17]  Tomoko Ito,et al.  Efficient in vivo gene transfection by stable DNA/PEI complexes coated by hyaluronic acid , 2008 .

[18]  H. Rammensee,et al.  Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid-specific, saturable and ion dependent , 2007, Gene Therapy.

[19]  W. Hennink,et al.  The Nuclear Pore Complex: The Gateway to Successful Nonviral Gene Delivery , 2006, Pharmaceutical Research.

[20]  L. Huang,et al.  Mechanism of efficient transfection of the nasal airway epithelium by hypotonic shock , 2005, Gene Therapy.

[21]  N. Elango,et al.  Optimized transfection of mRNA transcribed from a d(A/T)100 tail-containing vector. , 2005, Biochemical and biophysical research communications.

[22]  K. Docherty,et al.  Purification and Characterization of a Population of EGFP-Expressing Cells from the Developing Pancreas of a Neurogenin3/EGFP Transgenic Mouse , 2005, Organogenesis.

[23]  R. Rhoads,et al.  Novel "anti-reverse" cap analogs with superior translational properties. , 2003, RNA.

[24]  S. D. De Smedt,et al.  Mobility and stability of gene complexes in biogels. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[25]  J. Hecker,et al.  Stability of mRNA/cationic lipid lipoplexes in human and rat cerebrospinal fluid: methods and evidence for nonviral mRNA gene delivery to the central nervous system. , 2003, Human gene therapy.

[26]  J. Demeester,et al.  Pegylated GL67 lipoplexes retain their gene transfection activity after exposure to components of CF mucus , 2002, Gene Therapy.

[27]  M. Ogris,et al.  Peptide-mediated RNA delivery: a novel approach for enhanced transfection of primary and post-mitotic cells. , 2001, Nucleic acids research.

[28]  R. Müller,et al.  In vivo gene delivery to the lung using polyethylenimine and fractured polyamidoamine dendrimers , 2000, The journal of gene medicine.

[29]  J. Wolff,et al.  Hypothesis: naked plasmid DNA is taken up by cells in vivo by a receptor‐mediated process , 2000, The journal of gene medicine.

[30]  P. Ross,et al.  Lipoplex size is a major determinant of in vitro lipofection efficiency , 1999, Gene Therapy.

[31]  K Mechtler,et al.  The size of DNA/transferrin-PEI complexes is an important factor for gene expression in cultured cells , 1998, Gene Therapy.

[32]  D. Escande,et al.  Polyethylenimine but Not Cationic Lipids Promotes Transgene Delivery to the Nucleus in Mammalian Cells* , 1998, The Journal of Biological Chemistry.

[33]  R. Scheule,et al.  A concentrated and stable aerosol formulation of cationic lipid:DNA complexes giving high-level gene expression in mouse lung. , 1997, Human gene therapy.

[34]  S. Liebhaber,et al.  The stability of human beta-globin mRNA is dependent on structural determinants positioned within its 3' untranslated region. , 1996, Blood.

[35]  M. Wickens,et al.  The 3'-untranslated regions of c-mos and cyclin mRNAs stimulate translation by regulating cytoplasmic polyadenylation. , 1994, Genes & development.

[36]  Johnf . Thompson,et al.  Modulation of firefly luciferase stability and impact on studies of gene regulation. , 1991, Gene.

[37]  S. Mizutani,et al.  In vitro synthesis of an infectious RNA from cDNA clones of human rhinovirus type 14 , 1985, Journal of virology.

[38]  Mario R. Capecchi,et al.  High efficiency transformation by direct microinjection of DNA into cultured mammalian cells , 1980, Cell.

[39]  J. Willey,et al.  Molecular Cancer Stable Low-level Expression of P21 Waf1/cip1 in A549 Human Bronchogenic Carcinoma Cell Line-derived Clones Down-regulates E2f1 Mrna and Restores Cell Proliferation Control , 2006 .

[40]  I. Zuhorn,et al.  Size-dependent internalization of particles via the pathways of clathrin- and caveolae-mediated endocytosis. , 2004, The Biochemical journal.

[41]  L Meijer,et al.  Biochemical and cellular effects of roscovitine, a potent and selective inhibitor of the cyclin-dependent kinases cdc2, cdk2 and cdk5. , 1997, European journal of biochemistry.